Clinical Trial Update: Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase I/II trial of sodium stibogluconate for myelodysplastic syndromes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Northwestern University | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED